NIH, National Eye Institute (NEI)
Bethesda, MD USA

Our News on Newswise

Eylea Outperforms Other Drugs for Diabetic Macular Edema with Moderate or Worse Vision Loss

In an NIH-supported clinical trial comparing three drugs for diabetic macular edema (DME), Eylea (aflibercept) provided greater visual improvement, on average, than did Avastin (bevacizumab) or Lucentis (ranibizumab) when vision was 20/50 or worse...
13-Feb-2015 11:30 AM EST

NEI Sets Stage for New Clinical Trial to Tackle Dry Eye


National Eye Institute funded researchers launch an FDA-approved Phase I clinical trial to test the safety and efficacy of a novel drug called P-321 Ophthalmic Solution. The drug is applied as an eye drop and targets a unique mechanism involved in...
1-Oct-2014 11:10 AM EDT

Gene Profiling Technique to Accelerate Stem Cell Therapies for Eye Diseases


Researchers at the National Institutes of Health have developed a technique that will speed up the production of stem-cell derived tissues. The technique will help the researchers in their efforts to use patients’ skin cells to regenerate retinal...
16-Jul-2014 12:00 PM EDT

Rehabilitation Helps Prevent Depression From Age-Related Vision Loss


Depression is a common risk for people who have lost their vision from age-related macular degeneration (AMD), but a new study shows that a type of rehabilitation therapy can cut this risk in half.
7-Jul-2014 9:00 AM EDT

NIH Study Reveals Gene Critical to the Early Development of Cilia


Researchers at the National Eye Institute (NEI) have described the functions of a gene responsible for anchoring cilia – sensory hair-like extensions present on almost every cell of the body. They show in a mouse model that without the gene...
1-Jul-2014 1:45 PM EDT

Soothing Cells, Peaceful Protein Could Hold Promise for Treating Autoimmune Uveitis


Uveitis occurs when immune cells invade the eye, causing inflammation, swelling and vision loss. Researchers at the National Eye Institute (NEI) have found a unique type of immune cell and a secreted protein that, in tests on mice, can protect...
30-Jun-2014 12:00 PM EDT

Telemedicine Catches Blinding Disease in Premature Babies

Telemedicine is an effective strategy to screen for the potentially blinding disease known as retinopathy of prematurity (ROP), according to a study funded by the National Eye Institute (NEI). The investigators say that the approach, if adopted...
24-Jun-2014 4:00 PM EDT

Making Artificial Vision Look More Natural


In laboratory tests, researchers have used electrical stimulation of retinal cells to produce the same patterns of activity that occur when the retina sees a moving object. Although more work remains, this is a step toward restoring natural,...
5-Jun-2014 9:00 AM EDT

Our Experts on Newswise

Our experts are coming soon...

Our YouTube Videos